EPO Patents = 1

Forward Citations = 27

Loading Chart...

8 inventors (with patents filed for the assignee):

John Ford (4 out of 7 patents)

Patrick Round (3 out of 6 patents)

John Kastelein (3 out of 6 patents)

4. Atsuhiro Kawaguchi (2 out of 5 patents)

5. Koichi Tomiyasu (2 out of 5 patents)

6. Kozo Oka (2 out of 8 patents)

7. Johannes Paulus Gerardus Seerden (1 out of 1 patent)

8. Amandine Ledru (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 11013742 - Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases (2021-05-25),

2. 10653692 - Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases (2020-05-19),

3. 10300059 - Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and HMG CoA reductase inhibitors (2019-05-28),

4. 10112904 - Process for preparing synthetic intermediates for preparing tetrahydroquinoline derivatives (2018-10-30),

Company Overview

Dezima Pharma B.V. is a biotechnology company focused on developing innovative therapies for the treatment of cardiovascular diseases. Founded in 2012, the company is headquartered in Naarden, Netherlands. Dezima Pharma is committed to advancing drug discovery and development to address the global burden of cardiovascular disease.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#1 in DC Narden

#1,332 in Netherlands

DC Narden, Netherlands

Dezima Pharma B.v.

Forward Citations = 27

8 inventors:

John Ford (4 out of 7 patents)

Patrick Round (3 out of 6 patents)

John Kastelein (3 out of 6 patents)

4. Atsuhiro Kawaguchi (2 out of 5 patents)

5. Koichi Tomiyasu (2 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dezima Pharma B.v.. Retrieved from https://idiyas.com/company/dezima-pharma-b-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]